Compound ID | 675
VRC-3324
Class: Peptide deformylase inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Growth inhibitor; active against CAP |
| Institute where first reported: | Vernalis, UK; Novartis, Switzerland; Pfizer, US |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Phase 1 |
| Development status: | Inactive |
| Reason Dropped: | Toxicity issues (JS) and possible resistance issues |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/273137021 |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.